Augmentin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Bioequivalence Study of Clavamox, Film-coated Tablets, 875 mg + 125 mg Pharmtechnology LLC, Belarus), and Augmentin ®, Film-coated Tablets, 875 mg + 125 mg (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions
Condition:   Bioequivalence Interventions:   Drug: Clavamox;   Drug: Augmentin® Sponsors:   Pharmtechnology LLC;   ClinPharmInvest CRO Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2018 Category: Research Source Type: clinical trials

Bioequivalence Study of Clavamox, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml, and Augmentin ®, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml, in Healthy Volunteers Under Fasting Conditions
Condition:   Healthy Adults Interventions:   Drug: Clavamox;   Drug: Augmentin® Sponsors:   Pharmtechnology LLC;   ClinPharmInvest CRO Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 6, 2018 Category: Research Source Type: clinical trials